Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cleveland Clinic Foundation
Emboli-prevention devices provide better protection than GPIs
April 26th, 2005
Emboli-prevention devices (EPDs) provide better protection than glycoprotein IIb/IIIa inhibitors (GPIs) during carotid stenting. "Distal embolization is the main potential risk of carotid stenting, and techniques to minimize this risk are evolving," cardiologists in the United States explained. "Between July 1998 and March 2002, 305 consecutive patients who underwent elective or urgent percutaneous carotid intervention at The Cleveland Clinic were prospectively followed," as part of a study conducted by A.W. Chan and colleagues. "During this period, the clinical practice of carotid stenting evolved," from routine GPI use to routine EPD...
Source: Cardiovascular Business Week (2005-04-26)
|
